Engineered Nano-carrier Systems for the oral targeted delivery of Follicle Stimulating Hormone: Development, characterization, and, assessment of in vitro and in vivo performance and targetability.

[1]  M. Capucchio,et al.  Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies , 2019, Acta Diabetologica.

[2]  Sanyog Jain,et al.  Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations. , 2019, Nanomedicine.

[3]  C. Wyns,et al.  Fertility and infertility: Definition and epidemiology. , 2018, Clinical biochemistry.

[4]  A. Di Sotto,et al.  SPC Liposomes as Possible Delivery Systems for Improving Bioavailability of the Natural Sesquiterpene β-Caryophyllene: Lamellarity and Drug-Loading as Key Features for a Rational Drug Delivery Design , 2018, Pharmaceutics.

[5]  S. Mutalik,et al.  Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs , 2018, Expert opinion on drug delivery.

[6]  David J Brayden,et al.  A comparison of three Peyer’s patch “M‐like” cell culture models: particle uptake, bacterial interaction, and epithelial histology , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  David J Brayden,et al.  A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation , 2017, Nature Protocols.

[8]  A. Misra,et al.  Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability , 2017, BioMed research international.

[9]  Nidhi,et al.  Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH , 2017, Artificial cells, nanomedicine, and biotechnology.

[10]  Jingtian Han,et al.  Oral delivery of human growth hormone: Preparation, characterization, and pharmacokinetics , 2017, Journal of biomaterials applications.

[11]  Q. Ping,et al.  Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. , 2016, International journal of pharmaceutics.

[12]  R. Kharb,et al.  Nanostructured lipid carriers: versatile oral delivery vehicle , 2016, Future science OA.

[13]  A. Basit,et al.  Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies. , 2016, International journal of pharmaceutics.

[14]  H. Ohno.  Intestinal M cells. , 2016, Journal of biochemistry.

[15]  Guihua Fang,et al.  Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies , 2015 .

[16]  I. Tessaro,et al.  Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome , 2015, Journal of Ovarian Research.

[17]  R. Begg,et al.  A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine , 2015, Journal of Zhejiang University-SCIENCE B.

[18]  M. Ansari,et al.  Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats , 2015, Drug delivery.

[19]  T. Garg,et al.  Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. , 2015, International journal of pharmaceutics.

[20]  T. Garg,et al.  Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. , 2014, Drug delivery.

[21]  A. Direkvand-Moghadam,et al.  The global trend of infertility: an original review and meta-analysis , 2014 .

[22]  T. Garg,et al.  Recent approaches of lipid-based delivery system for lymphatic targeting via oral route , 2014, Journal of drug targeting.

[23]  S. Seth,et al.  Correlation between anti-Müllerian and follicle-stimulating hormone in female infertility , 2014 .

[24]  P. van Hoogevest,et al.  The use of natural and synthetic phospholipids as pharmaceutical excipients , 2014, European journal of lipid science and technology : EJLST.

[25]  Gaurav Kumar Jain,et al.  A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[26]  Sanyog Jain,et al.  Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[27]  F. Petraglia,et al.  The changing prevalence of infertility , 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[28]  Kinam Park,et al.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. , 2013, Advanced drug delivery reviews.

[29]  S. Boddu,et al.  Approaches for enhancing oral bioavailability of peptides and proteins. , 2013, International journal of pharmaceutics.

[30]  V. Préat,et al.  Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Amit Jain,et al.  Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. , 2012, Nanomedicine.

[32]  Rongrong Wang,et al.  Application of poly(ethylene glycol)–distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery , 2012, International journal of nanomedicine.

[33]  Megan A. Schwegel,et al.  Treatment of infertility in women. , 2012, Journal of the American Pharmacists Association : JAPhA.

[34]  B. Vaidya,et al.  Platelets directed liposomes for the delivery of streptokinase: development and characterization. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  Sanyog Jain,et al.  Solid lipid nanoparticles: an oral bioavailability enhancer vehicle , 2011, Expert opinion on drug delivery.

[36]  K. Masuda,et al.  Establishment and Evaluation of an in vitro M Cell Model using C2BBe1 Cells and Raji Cells , 2011, Bioscience and microflora.

[37]  D. Lo,et al.  Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[38]  J. Woodward,et al.  Chylomicrons Promote Intestinal Absorption and Systemic Dissemination of Dietary Antigen (Ovalbumin) in Mice , 2009, PloS one.

[39]  Chao-Chin Hsu,et al.  The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study , 2009, Reproductive biology and endocrinology : RB&E.

[40]  Y. Schneider,et al.  Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  R. Nahum,et al.  Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference? , 2009, Fertility and sterility.

[42]  Alabama.,et al.  Gonadotropin preparations: past, present, and future perspectives. , 2008, Fertility and sterility.

[43]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[44]  J. Boivin,et al.  International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. , 2007, Human reproduction.

[45]  Yves-Jacques Schneider,et al.  An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Wangxue Chen,et al.  Intestinal M cells: the fallible sentinels? , 2007, World journal of gastroenterology.

[47]  Yves-Jacques Schneider,et al.  Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[48]  E. Magosso,et al.  Enhanced Oral Bioavailability and Intestinal Lymphatic Transport of a Hydrophilic Drug Using Liposomes , 2006, Drug development and industrial pharmacy.

[49]  A. Bitonti,et al.  Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis. , 2005, Human reproduction.

[50]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[51]  B. van den Hazel,et al.  Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. , 2003, The Journal of clinical endocrinology and metabolism.

[52]  M. Garcia‐Fuentes,et al.  Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules , 2003 .

[53]  M. Elmazar,et al.  Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. , 2002, International journal of pharmaceutics.

[54]  T. Walsh,et al.  Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate , 2002, Antimicrobial Agents and Chemotherapy.

[55]  David J Brayden,et al.  Expression of specific markers and particle transport in a new human intestinal M-cell model. , 2000, Biochemical and biophysical research communications.

[56]  H. Katinger,et al.  Determination of liposome size distribution by flow cytometry. , 2000, Cytometry.

[57]  C. Miller,et al.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.

[58]  J. Kraehenbuhl,et al.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. , 1997, Science.

[59]  R. Grondelle,et al.  Spectroscopic characterization of recombinant follicle stimulating hormone , 1996 .

[60]  J. Mcghee,et al.  Characterization of liposome suspensions by flow cytometry. , 1989, Journal of immunological methods.

[61]  S. Mutalik,et al.  Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances , 2018, AAPS PharmSciTech.

[62]  P. R. Vuddanda,et al.  Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment , 2016 .

[63]  C. Hill,et al.  M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. , 2008, FEMS immunology and medical microbiology.

[64]  N. Greenfield.  Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.

[65]  R. Ogden,et al.  Development and characterization of a long-acting recombinant hFSH agonist. , 2003, Human reproduction.